DCGI Approves Phase II, III Clinical Trial of Covaxin in 2-18 Years
The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation […]
Say something
Tags: COVAXIN, eheallth news
SII endorse receiving Rs 1,732.50 crore for 11 crore doses of Covishield vaccine
The Serum Institute of India (SII) endorsed the government statement that a 100 percent advance of Rs 1,732.50 crore has […]
Bharat Biotech to Boost Covaxin Capacity to Rollout 700 Million Vaccine Doses Annually
Bharat Biotech has said that it will scale up manufacturing capacity to produce ~ 700 million doses of Covaxin annually. […]
COVID-19 vaccination drive to start from 16th January
COVID-19 vaccination in India will start from 16th January, after the forthcoming festivals including Lohri, Makar Sankranti, Pongal, Magh Bihu. […]
Haryana Health Minister tests Covid positive, weeks after taking trial dose of vaccine
Haryana Health Minister Anil Vij has tested positive for coronavirus, days after he took trial dose of coronavirus vaccine Covaxin. […]
Haryna’s Health Minister administered trial dose of indigenous Covaxin
Haryana’s Health Minister Anil Vij was administered a trial dose of potential coronavirus vaccine Covaxin as part of third phase […]
Bharat biotech’s Covaxin gets DCGI nod for phase 3 clinical trial
The Drugs Controller General of India (DCGI) has given approval to ‘Covaxin’ for phase 3 clinical trials with certain conditions. […]
Punjab: 3 govt medical colleges volunteer for phase-3 trial of ‘Covaxin’
Punjab’s three Government Medical Colleges will participate in the Phase 3 trials of the COVAXIN being tested by Bharat Biotech […]
‘COVAXIN, India’s indigenous vaccine may be launched in early 2021’
There seems to be no respite from Corona in near future as cases are constantly on the rise. With more […]
Covaxin human trial: 30-year old man given first dose at AIIMS
The phase-I human clinical trial of India’s first indigenously-developed vaccine against novel coronavirus, Covaxin, began at the AIIMS with the […]
Covaxin: Delhi-based Dr Dang selected as central lab for human clinical trials
A Delhi-based private laboratory has been selected as the central lab for human clinical trials of Covaxin, India”s indigenous COVID-19 […]
India’s first COVID-19 vaccine to begin human trails
Drug Controller General of India (DGCI), the country’s top drug regulator has given permission to Bharat Biotech India to conduct […]
-
-
Flipkart Health+ App Launched
06-04-2022
